Part of aim to become more flexible and competitive, company says
Evonik Degussa Corporation, a manufacturer and supplier of specialist chemicals headquartered in Germany, is to reduce its workforce at Tippecanoe Laboratories in Lafayette, Indiana, US by 45 as it aims to improve the flexibility of its business processes and increase competitiveness.
Tippecanoe Laboratories produces active pharmaceutical ingredients.
Evonik said affected employees would receive a severance package and outplacement services.
The transformation of our Lafayette facility is necessary in today's marketplace and it in no way reflects on the performance of the Tippecanoe team
Keith Baumann, Director of Human Resources at Tippecanoe Laboratories, said: ‘The transformation of our Lafayette facility is necessary in today’s marketplace and it in no way reflects on the performance of the outstanding Tippecanoe Laboratories team. We recognise this decision affects our employees and the Lafayette community and as a long standing member of the community, are committed to minimising any impact.’
Evonik’s goal is to increase its ‘agility’ said Jean-Luc Herbeaux, senior vice president and head of Evonik’s healthcare business.
‘We are focused on being a leading contract manufacturing organisation for the pharmaceutical industry and we are changing our operational model to further strengthen our position.
‘Our global sites like Tippecanoe Laboratories are core elements of this initiative.’
Evonik took over operation of Tippecanoe Laboratories at the beginning of 2010. With more than 650 employees, it is the company’s second-largest site in the US.